This segment focuses on the research and development of cannabinoid-based prescription medicines. Verde Science leverages its expertise in pharmaceutical research to identify, develop, and formulate novel drug candidates targeting various medical conditions. The company utilizes advanced technologies and methodologies in drug discovery, including pre-clinical studies and clinical trials. The therapeutic areas of focus include, but are not limited to, pain management, neurological disorders, and other conditions where cannabinoids may offer therapeutic benefits. The company aims to improve patient outcomes by providing effective and safe cannabinoid-based treatments. Verde Science's market positioning is based on its early-stage focus on cannabinoid research and development. Future opportunities include expanding the product pipeline, securing regulatory approvals, and establishing strategic partnerships. Regulatory and clinical aspects are critical, with a focus on FDA approval and clinical validation. Partnerships and collaborations with research institutions and pharmaceutical companies are essential for advancing the company's drug development programs.